Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed agreements to acquire a 19% equity interest in Yantai Andre Pectin (Andre Pectin), a China based producer of texturing ingredients. In addition, the parties have agreed that DSM has option rights to increase its stake in Andre Pectin to a majority stake at a later stage.

The agreements are subject to customary approvals and certain closing conditions, including the approval of the selling party's shareholders.

Closing is expected in Q3 2013.